| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.15e-04 | 4 | 88 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | deaminase binding | 1.15e-04 | 4 | 88 | 2 | GO:1990827 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.85e-04 | 6 | 88 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 3.01e-04 | 206 | 88 | 6 | GO:0043021 | |
| GeneOntologyMolecularFunction | actin filament binding | 5.04e-04 | 227 | 88 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.47e-04 | 151 | 88 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | gated channel activity | 6.85e-04 | 334 | 88 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 8.44e-04 | 10 | 88 | 2 | GO:0031701 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 8.99e-04 | 43 | 88 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.03e-03 | 465 | 88 | 8 | GO:0046873 | |
| GeneOntologyBiologicalProcess | muscle contraction | TPM1 TPM2 TPM3 TPM4 CACNA2D1 ANXA6 LMOD1 RCSD1 UTY RYR2 RYR3 | 8.45e-07 | 400 | 86 | 11 | GO:0006936 |
| GeneOntologyBiologicalProcess | muscle system process | TPM1 TPM2 TPM3 TPM4 CACNA2D1 ANXA6 LMOD1 COL14A1 RCSD1 UTY RYR2 RYR3 | 2.75e-06 | 547 | 86 | 12 | GO:0003012 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 5.77e-06 | 9 | 86 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | muscle structure development | TPM1 LUC7L FLOT2 ZEB1 NKD1 TLL2 LAMA2 SHOX2 LMOD1 COL14A1 ACTL6A CAMK1 RYR2 | 5.34e-05 | 858 | 86 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | positive regulation of neurotransmitter secretion | 1.51e-04 | 25 | 86 | 3 | GO:0001956 | |
| GeneOntologyBiologicalProcess | heart contraction | 2.48e-04 | 298 | 86 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 2.55e-04 | 6 | 86 | 2 | GO:0090367 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 2.89e-04 | 31 | 86 | 3 | GO:0045048 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.95e-04 | 217 | 86 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | heart process | 3.09e-04 | 309 | 86 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotransmitter transport | 3.18e-04 | 32 | 86 | 3 | GO:0051590 | |
| GeneOntologyBiologicalProcess | pattern specification process | 3.43e-04 | 526 | 86 | 9 | GO:0007389 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 3.56e-04 | 7 | 86 | 2 | GO:0090365 | |
| GeneOntologyBiologicalProcess | ribosome-associated ubiquitin-dependent protein catabolic process | 3.56e-04 | 7 | 86 | 2 | GO:1990116 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 3.56e-04 | 7 | 86 | 2 | GO:1900108 | |
| GeneOntologyCellularComponent | muscle thin filament tropomyosin | 2.93e-10 | 4 | 88 | 4 | GO:0005862 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 8.84e-08 | 27 | 88 | 5 | GO:0005865 | |
| GeneOntologyCellularComponent | myofilament | 2.17e-07 | 32 | 88 | 5 | GO:0036379 | |
| GeneOntologyCellularComponent | actin filament | 2.78e-06 | 146 | 88 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 5.95e-06 | 9 | 88 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.21e-05 | 277 | 88 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.54e-05 | 14 | 88 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | sarcomere | 8.74e-05 | 249 | 88 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM1 TPM2 TPM3 TPM4 MICAL1 FLOT2 HNRNPCL1 LMOD1 RCSD1 HNRNPCL2 | 1.53e-04 | 576 | 88 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | myofibril | 1.55e-04 | 273 | 88 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA2D1 FLOT2 ARRB1 SLC4A8 KCNA4 STXBP1 PTPRD EXOC3 NBEA ATP2B3 | 1.69e-04 | 583 | 88 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | pronucleus | 2.19e-04 | 28 | 88 | 3 | GO:0045120 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.24e-04 | 290 | 88 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.56e-04 | 73 | 88 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 2.60e-04 | 6 | 88 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber | 3.63e-04 | 7 | 88 | 2 | GO:0097457 | |
| GeneOntologyCellularComponent | sarcolemma | 1.25e-03 | 190 | 88 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM1 TPM2 TPM3 CEP170 TPM4 MICAL1 DNAL4 KRT78 DNAI2 LMOD1 RCSD1 RYR2 RYR3 | 1.27e-03 | 1179 | 88 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM1 TPM2 TPM3 CEP170 TPM4 MICAL1 DNAL4 KRT78 DNAI2 LMOD1 RCSD1 RYR2 RYR3 | 1.35e-03 | 1187 | 88 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM1 TPM2 TPM3 CEP170 TPM4 MICAL1 DNAL4 KRT78 DNAI2 LMOD1 RCSD1 | 1.36e-03 | 899 | 88 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | spliceosomal complex | 2.16e-03 | 215 | 88 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1B CACNA2D1 FLOT2 SLC4A8 KCNA4 STXBP1 PTPRD NBEA CAMK1 ATP2B3 | 2.26e-03 | 817 | 88 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic active zone | 2.98e-03 | 141 | 88 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | cation channel complex | 3.16e-03 | 235 | 88 | 5 | GO:0034703 | |
| Domain | TROPOMYOSIN | 4.19e-10 | 4 | 86 | 4 | PS00326 | |
| Domain | Tropomyosin | 4.19e-10 | 4 | 86 | 4 | IPR000533 | |
| Domain | Tropomyosin | 4.19e-10 | 4 | 86 | 4 | PF00261 | |
| Domain | DUF2012 | 3.76e-07 | 4 | 86 | 3 | PF09430 | |
| Domain | DUF2012 | 3.76e-07 | 4 | 86 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 5.19e-06 | 8 | 86 | 3 | IPR013784 | |
| Domain | CarboxyPept_regulatory_dom | 2.61e-05 | 13 | 86 | 3 | IPR014766 | |
| Domain | - | 2.61e-05 | 13 | 86 | 3 | 2.60.40.1120 | |
| Domain | CarboxyPept-like_regulatory | 6.12e-05 | 17 | 86 | 3 | IPR008969 | |
| Domain | Ryanrecept_TM4-6 | 6.27e-05 | 3 | 86 | 2 | IPR009460 | |
| Domain | RyR | 6.27e-05 | 3 | 86 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 6.27e-05 | 3 | 86 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 6.27e-05 | 3 | 86 | 2 | PF06459 | |
| Domain | Ryan_recept | 6.27e-05 | 3 | 86 | 2 | IPR013333 | |
| Domain | FHA | 2.84e-04 | 28 | 86 | 3 | SM00240 | |
| Domain | RIH_assoc | 3.11e-04 | 6 | 86 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 3.11e-04 | 6 | 86 | 2 | IPR013662 | |
| Domain | RIH_dom | 3.11e-04 | 6 | 86 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.11e-04 | 6 | 86 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.11e-04 | 6 | 86 | 2 | IPR015925 | |
| Domain | - | 3.11e-04 | 6 | 86 | 2 | 1.25.10.30 | |
| Domain | hnRNP_C | 3.11e-04 | 6 | 86 | 2 | IPR017347 | |
| Domain | RYDR_ITPR | 3.11e-04 | 6 | 86 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 3.11e-04 | 6 | 86 | 2 | PF08709 | |
| Domain | TPR | 3.24e-04 | 129 | 86 | 5 | SM00028 | |
| Domain | TPR_repeat | 3.73e-04 | 133 | 86 | 5 | IPR019734 | |
| Domain | FHA_DOMAIN | 3.86e-04 | 31 | 86 | 3 | PS50006 | |
| Domain | FHA | 3.86e-04 | 31 | 86 | 3 | PF00498 | |
| Domain | FHA_dom | 6.03e-04 | 36 | 86 | 3 | IPR000253 | |
| Domain | - | 6.03e-04 | 36 | 86 | 3 | 2.60.200.20 | |
| Domain | TPR-contain_dom | 6.45e-04 | 150 | 86 | 5 | IPR013026 | |
| Domain | MIR | 9.21e-04 | 10 | 86 | 2 | PS50919 | |
| Domain | MIR | 9.21e-04 | 10 | 86 | 2 | PF02815 | |
| Domain | MIR | 9.21e-04 | 10 | 86 | 2 | SM00472 | |
| Domain | MIR_motif | 9.21e-04 | 10 | 86 | 2 | IPR016093 | |
| Domain | TPR_REGION | 9.91e-04 | 165 | 86 | 5 | PS50293 | |
| Domain | TPR | 9.91e-04 | 165 | 86 | 5 | PS50005 | |
| Domain | SMAD_FHA_domain | 1.77e-03 | 52 | 86 | 3 | IPR008984 | |
| Domain | TPR_8 | 1.87e-03 | 53 | 86 | 3 | PF13181 | |
| Domain | Ion_trans_dom | 1.90e-03 | 114 | 86 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.90e-03 | 114 | 86 | 4 | PF00520 | |
| Domain | - | 2.68e-03 | 207 | 86 | 5 | 1.25.40.10 | |
| Domain | ConA-like_dom | 3.42e-03 | 219 | 86 | 5 | IPR013320 | |
| Domain | - | 4.37e-03 | 333 | 86 | 6 | 2.130.10.10 | |
| Domain | TPR-like_helical_dom | 4.44e-03 | 233 | 86 | 5 | IPR011990 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.50e-03 | 335 | 86 | 6 | IPR015943 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 3.68e-08 | 43 | 64 | 6 | M1429 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 8.99e-08 | 83 | 64 | 7 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.58e-07 | 90 | 64 | 7 | M835 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.10e-07 | 203 | 64 | 9 | M5485 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.12e-07 | 147 | 64 | 8 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.83e-07 | 151 | 64 | 8 | M39329 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 4.81e-07 | 35 | 64 | 5 | MM15114 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 7.54e-07 | 165 | 64 | 8 | MM15026 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.48e-06 | 79 | 64 | 6 | M17673 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.43e-05 | 11 | 64 | 3 | M47958 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.82e-05 | 35 | 64 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 2.04e-05 | 36 | 64 | 4 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 2.54e-05 | 38 | 64 | 4 | M39549 | |
| Pubmed | A systematic nomenclature for mammalian tropomyosin isoforms. | 3.83e-11 | 4 | 88 | 4 | 25369766 | |
| Pubmed | Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts. | 3.83e-11 | 4 | 88 | 4 | 16765662 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 23792823 | ||
| Pubmed | 2.35e-09 | 22 | 88 | 5 | 14627618 | ||
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | TPM3 FLOT2 HNRNPCL1 PA2G4 L1TD1 ZNF638 NASP NCL HNRNPCL2 SFN | 1.28e-08 | 332 | 88 | 10 | 30595499 |
| Pubmed | Vertebrate tropomyosin: distribution, properties and function. | 1.57e-08 | 3 | 88 | 3 | 11563548 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 36011023 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 7568216 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.57e-08 | 3 | 88 | 3 | 25576386 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 3865200 | ||
| Pubmed | Ca2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins. | 6.25e-08 | 4 | 88 | 3 | 9092943 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 6.25e-08 | 4 | 88 | 3 | 31833031 | |
| Pubmed | Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease. | 6.25e-08 | 4 | 88 | 3 | 1516138 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 9108196 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 9267806 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 1.49e-07 | 156 | 88 | 7 | 30409884 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 1.72e-07 | 238 | 88 | 8 | 35864588 | |
| Pubmed | 3.60e-07 | 601 | 88 | 11 | 33658012 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 4.35e-07 | 269 | 88 | 8 | 29511261 | |
| Pubmed | TPM1 TPM2 TPM3 CEP170 LUC7L ZBTB16 ZBTB40 LAMA2 COL14A1 BIRC6 | 5.41e-07 | 497 | 88 | 10 | 23414517 | |
| Pubmed | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. | 5.44e-07 | 7 | 88 | 3 | 19118250 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 8.69e-07 | 8 | 88 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.30e-06 | 9 | 88 | 3 | 36261522 | |
| Pubmed | 1.30e-06 | 32 | 88 | 4 | 21951318 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM1 TPM2 TPM3 TPM4 FLOT2 PA2G4 ANXA6 NASP BOD1L1 NCL ACTL6A SFN | 1.52e-06 | 847 | 88 | 12 | 35235311 |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 2.55e-06 | 11 | 88 | 3 | 32820719 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.64e-06 | 38 | 88 | 4 | 30786075 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 2.73e-06 | 344 | 88 | 8 | 30333137 | |
| Pubmed | TPM1 TPM2 TPM3 TPM4 HNRNPCL1 ARRB1 STXBP1 ABCB5 BOD1L1 NCL ATP2B3 HNRNPCL2 RYR2 ZNF541 SFN | 3.15e-06 | 1442 | 88 | 15 | 35575683 | |
| Pubmed | Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. | 3.26e-06 | 40 | 88 | 4 | 20381070 | |
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 8424456 | ||
| Pubmed | HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. | 3.61e-06 | 41 | 88 | 4 | 24614889 | |
| Pubmed | 4.45e-06 | 259 | 88 | 7 | 31162944 | ||
| Pubmed | Isolation and characterization of a cDNA that encodes mouse fibroblast tropomyosin isoform 2. | 6.33e-06 | 2 | 88 | 2 | 3244365 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 30545627 | ||
| Pubmed | High molecular weight tropomyosins regulate osteoclast cytoskeletal morphology. | 6.33e-06 | 2 | 88 | 2 | 18674650 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27649540 | ||
| Pubmed | PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. | 6.33e-06 | 2 | 88 | 2 | 29358655 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 38579707 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24889613 | ||
| Pubmed | ABCB5-ZEB1 Axis Promotes Invasion and Metastasis in Breast Cancer Cells. | 6.33e-06 | 2 | 88 | 2 | 28281973 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 6.33e-06 | 2 | 88 | 2 | 21531043 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 16678258 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22798622 | ||
| Pubmed | Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics. | 6.33e-06 | 2 | 88 | 2 | 16501024 | |
| Pubmed | Variants in tropomyosins TPM2 and TPM3 causing muscle hypertonia. | 6.33e-06 | 2 | 88 | 2 | 38219297 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22740512 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24507666 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 8760295 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 14602720 | ||
| Pubmed | Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. | 6.33e-06 | 2 | 88 | 2 | 17416600 | |
| Pubmed | Renaturation of skeletal muscle tropomyosin: implications for in vivo assembly. | 6.33e-06 | 2 | 88 | 2 | 3857586 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 8898078 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 14550562 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24692096 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 1796905 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 23205574 | ||
| Pubmed | Regulation of Actin Filament Length by Muscle Isoforms of Tropomyosin and Cofilin. | 6.33e-06 | 2 | 88 | 2 | 32560136 | |
| Pubmed | Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. | 6.33e-06 | 2 | 88 | 2 | 7684495 | |
| Pubmed | Munc18: a presynaptic transmitter release site N type (CaV2.2) calcium channel interacting protein. | 6.33e-06 | 2 | 88 | 2 | 19170253 | |
| Pubmed | Specific features of neuronal size and shape are regulated by tropomyosin isoforms. | 6.33e-06 | 2 | 88 | 2 | 15888546 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 14985349 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 30285720 | ||
| Pubmed | FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity. | 6.33e-06 | 2 | 88 | 2 | 27976512 | |
| Pubmed | Human hTM alpha gene: expression in muscle and nonmuscle tissue. | 6.33e-06 | 2 | 88 | 2 | 3336363 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 17951248 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9473354 | ||
| Pubmed | 8.56e-06 | 16 | 88 | 3 | 16494860 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPM3 CEP170 LUC7L CACNA2D1 FLOT2 KRT78 PA2G4 ANXA6 ZNF638 EXOC3 NCL ASCC3 | 1.05e-05 | 1024 | 88 | 12 | 24711643 |
| Pubmed | 1.10e-05 | 54 | 88 | 4 | 22266860 | ||
| Pubmed | TPM1 TPM3 CEP170 TPM4 MICAL1 CACNA2D1 FLOT2 KRT78 HNRNPCL1 STXBP1 NBEA NCL ATP2B3 HNRNPCL2 | 1.39e-05 | 1431 | 88 | 14 | 37142655 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 18403125 | ||
| Pubmed | Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta. | 1.90e-05 | 3 | 88 | 2 | 15897890 | |
| Pubmed | Tropomyosin isoforms regulate cofilin 1 activity by modulating actin filament conformation. | 1.90e-05 | 3 | 88 | 2 | 31996302 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 18434746 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 1.90e-05 | 3 | 88 | 2 | 29730765 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.90e-05 | 3 | 88 | 2 | 9204703 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 7876312 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 21881589 | ||
| Pubmed | Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. | 1.90e-05 | 3 | 88 | 2 | 8120097 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 27020427 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.90e-05 | 3 | 88 | 2 | 12213830 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 11356630 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 9242641 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.90e-05 | 3 | 88 | 2 | 10788707 | |
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 1.90e-05 | 3 | 88 | 2 | 15024040 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.90e-05 | 3 | 88 | 2 | 7621815 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 18643873 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 11159936 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 1.90e-05 | 3 | 88 | 2 | 29208674 | |
| Pubmed | h2-Calponin is regulated by mechanical tension and modifies the function of actin cytoskeleton. | 1.90e-05 | 3 | 88 | 2 | 16236705 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.90e-05 | 3 | 88 | 2 | 10473538 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 7959768 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 8886980 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 9400381 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.90e-05 | 3 | 88 | 2 | 4600883 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 7635066 | ||
| Pubmed | 1.93e-05 | 591 | 88 | 9 | 15231748 | ||
| Interaction | RYR2 interactions | 5.96e-09 | 58 | 88 | 7 | int:RYR2 | |
| Interaction | PLCH2 interactions | 1.64e-07 | 12 | 88 | 4 | int:PLCH2 | |
| Interaction | PIM3 interactions | 3.25e-07 | 63 | 88 | 6 | int:PIM3 | |
| Interaction | ZIC3 interactions | 4.00e-06 | 25 | 88 | 4 | int:ZIC3 | |
| Interaction | PRKAG2 interactions | 1.19e-05 | 68 | 88 | 5 | int:PRKAG2 | |
| Interaction | DYRK3 interactions | 3.68e-05 | 43 | 88 | 4 | int:DYRK3 | |
| Interaction | RGS12 interactions | 4.41e-05 | 45 | 88 | 4 | int:RGS12 | |
| Interaction | TFPT interactions | 7.22e-05 | 160 | 88 | 6 | int:TFPT | |
| Interaction | NR3C1 interactions | FLOT2 ARRB1 ZBTB16 STXBP1 ANXA6 LMOD1 NBEA NCL UTY ATP2B3 NOMO3 HNRNPCL2 RYR2 SFN | 7.88e-05 | 974 | 88 | 14 | int:NR3C1 |
| Interaction | SNAPIN interactions | 9.77e-05 | 169 | 88 | 6 | int:SNAPIN | |
| Interaction | SCN9A interactions | 1.01e-04 | 21 | 88 | 3 | int:SCN9A | |
| Interaction | ACTN2 interactions | 1.04e-04 | 171 | 88 | 6 | int:ACTN2 | |
| Interaction | MAST2 interactions | 1.20e-04 | 58 | 88 | 4 | int:MAST2 | |
| GeneFamily | Tropomyosins | 1.43e-10 | 4 | 64 | 4 | 777 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.69e-05 | 3 | 64 | 2 | 287 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.35e-04 | 115 | 64 | 4 | 769 | |
| GeneFamily | Zinc fingers CXXC-type | 7.96e-04 | 12 | 64 | 2 | 136 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 9.38e-04 | 13 | 64 | 2 | 685 | |
| GeneFamily | Dyneins, axonemal | 1.62e-03 | 17 | 64 | 2 | 536 | |
| GeneFamily | DNA helicases | 1.62e-03 | 17 | 64 | 2 | 1167 | |
| GeneFamily | WD repeat domain containing | 2.34e-03 | 262 | 64 | 5 | 362 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.80e-03 | 26 | 64 | 2 | 253 | |
| GeneFamily | EF-hand domain containing | 7.55e-03 | 219 | 64 | 4 | 863 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.28e-06 | 177 | 88 | 7 | M39245 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 9.94e-06 | 69 | 88 | 5 | BM Top 100 - saphenous vein | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.38e-10 | 188 | 88 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.03e-09 | 189 | 88 | 8 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.03e-09 | 189 | 88 | 8 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.03e-09 | 189 | 88 | 8 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-09 | 190 | 88 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-09 | 190 | 88 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-09 | 190 | 88 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.56e-09 | 192 | 88 | 8 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.36e-09 | 196 | 88 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.81e-09 | 198 | 88 | 8 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-08 | 177 | 88 | 7 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.05e-08 | 180 | 88 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.32e-08 | 181 | 88 | 7 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.89e-08 | 183 | 88 | 7 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 9.15e-08 | 187 | 88 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.49e-08 | 188 | 88 | 7 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.49e-08 | 188 | 88 | 7 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.84e-08 | 189 | 88 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 190 | 88 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 190 | 88 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-07 | 191 | 88 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-07 | 191 | 88 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-07 | 194 | 88 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-07 | 194 | 88 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.22e-07 | 195 | 88 | 7 | dba2a87efd7e067c094c4b367feb4138cab62735 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-07 | 195 | 88 | 7 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 196 | 88 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-07 | 196 | 88 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 196 | 88 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 197 | 88 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.30e-07 | 197 | 88 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.35e-07 | 198 | 88 | 7 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.40e-07 | 199 | 88 | 7 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-07 | 200 | 88 | 7 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 200 | 88 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 200 | 88 | 7 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 200 | 88 | 7 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.06e-07 | 143 | 88 | 6 | 9bfb3674c8f011b9cf928b522777b8d54478db8d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.03e-07 | 153 | 88 | 6 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.29e-07 | 158 | 88 | 6 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.13e-07 | 161 | 88 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.39e-07 | 165 | 88 | 6 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.72e-07 | 166 | 88 | 6 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.20e-06 | 172 | 88 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.24e-06 | 173 | 88 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-06 | 173 | 88 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-06 | 173 | 88 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-06 | 181 | 88 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 1.61e-06 | 181 | 88 | 6 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.61e-06 | 181 | 88 | 6 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-06 | 182 | 88 | 6 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-06 | 182 | 88 | 6 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.77e-06 | 184 | 88 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 186 | 88 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-06 | 187 | 88 | 6 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 188 | 88 | 6 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-06 | 188 | 88 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-06 | 189 | 88 | 6 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.07e-06 | 189 | 88 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.07e-06 | 189 | 88 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.07e-06 | 189 | 88 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.13e-06 | 190 | 88 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-06 | 191 | 88 | 6 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.20e-06 | 191 | 88 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-06 | 192 | 88 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-06 | 192 | 88 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-06 | 193 | 88 | 6 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-06 | 193 | 88 | 6 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-06 | 193 | 88 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-06 | 193 | 88 | 6 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.33e-06 | 193 | 88 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-06 | 194 | 88 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-06 | 194 | 88 | 6 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 194 | 88 | 6 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 194 | 88 | 6 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 194 | 88 | 6 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 194 | 88 | 6 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-06 | 195 | 88 | 6 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 195 | 88 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.48e-06 | 195 | 88 | 6 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 195 | 88 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.48e-06 | 195 | 88 | 6 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 195 | 88 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 195 | 88 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.48e-06 | 195 | 88 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 88 | 6 | cda3681f032f740cb09c64c62b9153cb62dbb5d2 | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 2.55e-06 | 196 | 88 | 6 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 88 | 6 | f78951b460913866d092ba92af70ea76a2afa73e | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-06 | 196 | 88 | 6 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 88 | 6 | b55aa507429ddce89ad4f42ab6daeca2f34fd676 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-06 | 196 | 88 | 6 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 88 | 6 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 88 | 6 | 69ad90a429af4dad5a45556544224001ebcb1607 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 88 | 6 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 88 | 6 | 4da96672a9c72268cfcc82d61eb3caae6e02d4c4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-06 | 197 | 88 | 6 | 398a66c06df63567b176ab2cc85e27837e94d0d9 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.63e-06 | 197 | 88 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 2.63e-06 | 197 | 88 | 6 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.63e-06 | 197 | 88 | 6 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.63e-06 | 197 | 88 | 6 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| Drug | CP-31 | 9.57e-11 | 9 | 88 | 5 | CID000452624 | |
| Drug | amphidinolide D | 1.04e-09 | 5 | 88 | 4 | CID006439238 | |
| Drug | eudistomin M | 1.04e-09 | 5 | 88 | 4 | CID000145927 | |
| Drug | didansylcystine | 3.11e-09 | 6 | 88 | 4 | CID000167721 | |
| Drug | Topanol Ca | 7.23e-09 | 7 | 88 | 4 | CID000092905 | |
| Drug | TCNB | 1.99e-08 | 119 | 88 | 8 | CID000008330 | |
| Drug | NpCaM | 3.02e-08 | 48 | 88 | 6 | CID000122259 | |
| Drug | IASL | 4.30e-08 | 10 | 88 | 4 | CID002724305 | |
| Drug | NSC3260 | 6.57e-08 | 195 | 88 | 9 | CID000220461 | |
| Drug | AC1NRD2N | 1.01e-07 | 12 | 88 | 4 | CID005289322 | |
| Drug | TMBr-3 | 1.45e-07 | 13 | 88 | 4 | CID000518955 | |
| Drug | N,N'-p-phenylenedimaleimide | 1.96e-07 | 34 | 88 | 5 | CID000076765 | |
| Drug | AC1MP21W | 2.02e-07 | 14 | 88 | 4 | CID003378340 | |
| Drug | goniodomin A | 2.02e-07 | 14 | 88 | 4 | CID006440832 | |
| Drug | AC1NSKFN | 2.64e-07 | 36 | 88 | 5 | CID005311324 | |
| Drug | K-Cl | TPM1 TPM2 TPM3 TPM4 CACNA1B CACNA2D1 ZEB1 LDHAL6A NCL ACTL6A ATP2B3 RYR2 RYR3 | 2.69e-07 | 567 | 88 | 13 | CID000004873 |
| Drug | conen | 2.75e-07 | 15 | 88 | 4 | CID000093117 | |
| Drug | A-G-T-C | 2.75e-07 | 15 | 88 | 4 | CID003037868 | |
| Drug | AC1Q5G4B | 3.49e-07 | 38 | 88 | 5 | CID000207983 | |
| Drug | DABMI | 4.77e-07 | 17 | 88 | 4 | CID000137371 | |
| Drug | ethylene glycol tetraacetic acid | 7.41e-07 | 44 | 88 | 5 | CID000006207 | |
| Drug | benzophenone-4-iodoacetamide | 7.72e-07 | 19 | 88 | 4 | CID000131289 | |
| Drug | chloro-m-cresol | 1.11e-06 | 6 | 88 | 3 | CID000012008 | |
| Drug | 7-azatryptophan | 1.74e-06 | 23 | 88 | 4 | CID005354789 | |
| Drug | dansylaziridine | 1.74e-06 | 23 | 88 | 4 | CID000104008 | |
| Drug | Azumoleno | 1.93e-06 | 7 | 88 | 3 | CID000056259 | |
| Drug | NSC 32050 | 4.60e-06 | 29 | 88 | 4 | CID000022780 | |
| Drug | 5-IAF | 5.71e-06 | 66 | 88 | 5 | CID000123822 | |
| Drug | gallopamil | 6.15e-06 | 67 | 88 | 5 | CID000001234 | |
| Drug | NSC7524 | 6.84e-06 | 182 | 88 | 7 | CID000005657 | |
| Drug | AC1MNW2N | 7.64e-06 | 70 | 88 | 5 | CID003359490 | |
| Drug | CNS 1145 | 7.82e-06 | 33 | 88 | 4 | CID000190902 | |
| Drug | IHC-64 | 7.82e-06 | 33 | 88 | 4 | CID000162753 | |
| Drug | fluo-3 | 7.92e-06 | 122 | 88 | 6 | CID000104978 | |
| Drug | Dichloro-phen | 8.84e-06 | 34 | 88 | 4 | CID000003037 | |
| Drug | dihydropyridine | 1.00e-05 | 193 | 88 | 7 | CID000104822 | |
| Drug | uranyl acetate | 1.12e-05 | 36 | 88 | 4 | CID000010915 | |
| Drug | nisoldipine | 1.30e-05 | 78 | 88 | 5 | CID000004499 | |
| Drug | XeC compound | 1.87e-05 | 84 | 88 | 5 | CID000005701 | |
| Drug | nimodipine | 2.12e-05 | 145 | 88 | 6 | CID000004497 | |
| Drug | 3-(2-carboxyindol-3-yl)propionic acid | 2.29e-05 | 43 | 88 | 4 | CID000169313 | |
| Drug | silaned | 2.29e-05 | 43 | 88 | 4 | CID006335299 | |
| Drug | fluorescein isothiocyanate | 2.29e-05 | 147 | 88 | 6 | CID000018730 | |
| Drug | FPL 64176 | 2.45e-05 | 15 | 88 | 3 | CID000003423 | |
| Drug | Bay K 8644 | 2.57e-05 | 150 | 88 | 6 | CID000002303 | |
| Drug | benzophenone-4-maleimide | 2.75e-05 | 45 | 88 | 4 | CID000146390 | |
| Drug | AC1L9NBR | 2.90e-05 | 92 | 88 | 5 | CID000449625 | |
| Drug | nor-BNI | 3.00e-05 | 46 | 88 | 4 | CID000004533 | |
| Drug | nifedipine | CACNA1B CACNA2D1 LDHAL6A ABCB5 COL14A1 BIRC6 ATP2B3 RYR2 RYR3 | 3.26e-05 | 415 | 88 | 9 | CID000004485 |
| Drug | pemoline | 3.27e-05 | 47 | 88 | 4 | CID000004723 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 3.37e-05 | 233 | 88 | 7 | CID000005114 | |
| Drug | manidipine | 3.39e-05 | 95 | 88 | 5 | CID000004008 | |
| Drug | isotetrandrine | 3.75e-05 | 97 | 88 | 5 | CID000005422 | |
| Drug | G 2 (antioxidant) | 3.87e-05 | 49 | 88 | 4 | CID000202003 | |
| Drug | 2-hydroxycarbazole | 4.42e-05 | 3 | 88 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 4.42e-05 | 3 | 88 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 4.42e-05 | 3 | 88 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 4.42e-05 | 3 | 88 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 4.42e-05 | 3 | 88 | 2 | CID000127713 | |
| Drug | aminodantrolene | 4.42e-05 | 3 | 88 | 2 | CID009570289 | |
| Drug | loperamide | 5.48e-05 | 105 | 88 | 5 | CID000003954 | |
| Drug | dansyl chloride | 6.27e-05 | 108 | 88 | 5 | CID000011801 | |
| Drug | Cinildipine | 6.56e-05 | 56 | 88 | 4 | CID000002752 | |
| Drug | acrylodan | 6.56e-05 | 56 | 88 | 4 | CID000104901 | |
| Drug | AC1NSKPI | 7.04e-05 | 57 | 88 | 4 | CID005311482 | |
| Drug | indo-1/AM | 7.06e-05 | 21 | 88 | 3 | CID000123918 | |
| Drug | thulium | 7.14e-05 | 111 | 88 | 5 | CID000023961 | |
| Drug | purealin | 7.54e-05 | 58 | 88 | 4 | CID006419303 | |
| Drug | etorphine | 8.06e-05 | 59 | 88 | 4 | CID000026721 | |
| Drug | nilvadipine | 8.61e-05 | 60 | 88 | 4 | CID000004494 | |
| Drug | AC 110 | 8.82e-05 | 4 | 88 | 2 | CID000022860 | |
| Drug | PCB74 | 8.82e-05 | 4 | 88 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 8.82e-05 | 4 | 88 | 2 | CID006444275 | |
| Drug | AHC-52 | 8.82e-05 | 4 | 88 | 2 | CID000164115 | |
| Drug | SC 38249 | 8.82e-05 | 4 | 88 | 2 | CID000134834 | |
| Drug | teludipine | 8.82e-05 | 4 | 88 | 2 | CID006436165 | |
| Drug | Gabapentin | 8.82e-05 | 4 | 88 | 2 | DB00996 | |
| Drug | AC1L1U7A | 8.82e-05 | 4 | 88 | 2 | CID000035682 | |
| Drug | IAA-94 | 9.19e-05 | 61 | 88 | 4 | CID000003667 | |
| Drug | NSC759576 | 9.87e-05 | 191 | 88 | 6 | CID000003075 | |
| Drug | lercanidipine | 1.04e-04 | 63 | 88 | 4 | CID000065866 | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 4120_UP | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; PC3; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 6314_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 4293_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 3540_DN | |
| Drug | AC1L1I3V | 1.21e-04 | 25 | 88 | 3 | CID000004411 | |
| Drug | bepridil | 1.30e-04 | 126 | 88 | 5 | CID000002351 | |
| Drug | S 8510 | 1.47e-04 | 5 | 88 | 2 | CID005488383 | |
| Drug | Sdz 280 446 | 1.47e-04 | 5 | 88 | 2 | CID000164287 | |
| Drug | SDB-ethylenediamine | 1.47e-04 | 5 | 88 | 2 | CID006438957 | |
| Drug | AC1L2AC7 | 1.49e-04 | 69 | 88 | 4 | CID000068733 | |
| Drug | eniluracil | 1.53e-04 | 27 | 88 | 3 | CID000043157 | |
| Drug | pyrene | 1.56e-04 | 131 | 88 | 5 | CID000031423 | |
| Drug | AC1L1D8L | 1.66e-04 | 71 | 88 | 4 | CID000002241 | |
| Drug | flecainide | 1.66e-04 | 71 | 88 | 4 | CID000003355 | |
| Drug | azidopine | 1.70e-04 | 28 | 88 | 3 | CID000656406 | |
| Drug | CAS 298-57-7 | 1.85e-04 | 73 | 88 | 4 | CID000002761 | |
| Drug | lanthanum | 1.86e-04 | 136 | 88 | 5 | CID000023926 | |
| Drug | AC1NRBPQ | 1.92e-04 | 137 | 88 | 5 | CID005288569 | |
| Drug | AC1L1B35 | 1.95e-04 | 74 | 88 | 4 | CID000001263 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.04e-05 | 195 | 84 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.40e-05 | 3 | 84 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Cap Myopathy | 2.40e-05 | 3 | 84 | 2 | C3710589 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.40e-05 | 3 | 84 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Inflammatory Myofibroblastic Tumor | 1.19e-04 | 6 | 84 | 2 | C0334121 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 1.19e-04 | 6 | 84 | 2 | C1834523 | |
| Disease | Congenital myopathy with fiber type disproportion | 1.19e-04 | 6 | 84 | 2 | cv:C0546264 | |
| Disease | Nemaline Myopathy, Childhood Onset | 1.67e-04 | 7 | 84 | 2 | C0546125 | |
| Disease | Myopathies, Nemaline | 2.22e-04 | 8 | 84 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 2.22e-04 | 8 | 84 | 2 | cv:C0206157 | |
| Disease | Distal arthrogryposis | 2.85e-04 | 9 | 84 | 2 | cv:C0265213 | |
| Disease | Intellectual Disability | 2.90e-04 | 447 | 84 | 7 | C3714756 | |
| Disease | Macrocephaly | 4.33e-04 | 11 | 84 | 2 | C0221355 | |
| Disease | Congenital myopathy (disorder) | 5.19e-04 | 12 | 84 | 2 | C0270960 | |
| Disease | Global developmental delay | 5.76e-04 | 133 | 84 | 4 | C0557874 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 6.12e-04 | 13 | 84 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 6.12e-04 | 13 | 84 | 2 | C0175709 | |
| Disease | salicylurate measurement | 6.12e-04 | 13 | 84 | 2 | EFO_0010532 | |
| Disease | X-linked centronuclear myopathy | 6.12e-04 | 13 | 84 | 2 | C0410203 | |
| Disease | Congenital Structural Myopathy | 6.12e-04 | 13 | 84 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, 1 | 6.12e-04 | 13 | 84 | 2 | C4551952 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 7.13e-04 | 14 | 84 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 7.13e-04 | 14 | 84 | 2 | C0410207 | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 7.13e-04 | 14 | 84 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 8.21e-04 | 15 | 84 | 2 | C3645536 | |
| Disease | erythritol measurement | 1.06e-03 | 17 | 84 | 2 | EFO_0021171 | |
| Disease | Congenital Fiber Type Disproportion | 1.19e-03 | 18 | 84 | 2 | C0546264 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.30e-03 | 75 | 84 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Esophageal Neoplasms | 1.45e-03 | 78 | 84 | 3 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 1.45e-03 | 78 | 84 | 3 | C0546837 | |
| Disease | exercise test | 1.47e-03 | 20 | 84 | 2 | EFO_0004328 | |
| Disease | Liver Cirrhosis, Experimental | 1.63e-03 | 774 | 84 | 8 | C0023893 | |
| Disease | Autism Spectrum Disorders | 1.86e-03 | 85 | 84 | 3 | C1510586 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.02e-03 | 801 | 84 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Squamous cell carcinoma of esophagus | 2.55e-03 | 95 | 84 | 3 | C0279626 | |
| Disease | azoospermia (implicated_via_orthology) | 2.68e-03 | 27 | 84 | 2 | DOID:14227 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEEVEARKMIDKVFG | 511 | Q5SW79 | |
| EMVSEDEDGKLGFKV | 4541 | Q9NR09 | |
| MKGAVEKGEELSCEE | 26 | P31947 | |
| RMTDDIDKISDGIGD | 166 | Q2M3G0 | |
| KIGEAEAAVIEAMGK | 321 | Q14254 | |
| ERDDGSTLMEIDGDK | 46 | O96019 | |
| EEKPAGEEAEMEKAT | 301 | Q6JBY9 | |
| GEEAEMEKATEVKGE | 306 | Q6JBY9 | |
| EDENMGGEDKEKKET | 1581 | Q6RI45 | |
| EMRLKEKGKAEGRDE | 516 | Q9GZS0 | |
| EGKKEVEADDVMRSG | 1106 | Q00975 | |
| LKGMKDDKEEEEDGT | 396 | P49407 | |
| SAEGGEMEEREKKKA | 336 | Q16720 | |
| DKEVGSMKADDKCGV | 691 | Q8WXS8 | |
| KAMEGAGTDEKALIE | 446 | P08133 | |
| EGEEEGKEDKKIVME | 61 | Q8TBY9 | |
| GLGSGDEKKMERVSE | 96 | Q969G9 | |
| REKNGNEEGEERMTK | 721 | P69849 | |
| DEGERKMEKEELDVS | 181 | Q9UJX4 | |
| RAFEDEKKARMGVVE | 281 | Q9UQ80 | |
| KDETHVKMESEGGAE | 231 | O60812 | |
| REKNGNEEGEERMTK | 721 | Q5JPE7 | |
| GKMASRRSEEKEAGE | 356 | Q9NQ29 | |
| KDETHVKMESEGGAE | 231 | B2RXH8 | |
| GQEGSEEADMRRKKI | 591 | Q96PY6 | |
| EVRKDQDSVGEMKDE | 756 | O60524 | |
| MAEEKGGKQVLEESA | 1 | Q5T655 | |
| MGETEGKKDEADYKR | 1 | O96015 | |
| RAGGNTDMKKEDEKV | 241 | P29536 | |
| GSKERMCGEELEDTK | 151 | Q8N8A8 | |
| REKNGNEEGEERMTK | 721 | Q15155 | |
| DVDGVFLSKMELEGK | 221 | Q8N1N4 | |
| AEDAGGKKLRLEMEA | 651 | Q8TDZ2 | |
| KLFGESRGENEEMEK | 1756 | P24043 | |
| KEGEEKEERAVAEEM | 376 | Q9UMN6 | |
| GKTREGAEDKMTSGD | 96 | Q9NX62 | |
| DKEQDSEMEKGGRED | 171 | P49321 | |
| AKEAMEDGEIDGNKV | 626 | P19338 | |
| DMEKCEAAAKDIRGE | 71 | Q8NBN7 | |
| IAKEALEGKEGSMEN | 51 | Q14012 | |
| TREAIGHMKEGEEEK | 396 | Q3MIT2 | |
| ERAGTVMEEKDGSGI | 2241 | Q8NFC6 | |
| IEDVKMAFDRDGEKA | 321 | P52757 | |
| EDVRAAAGKPDKMEE | 286 | Q96EP1 | |
| KVEIRNKMIDGESGE | 571 | P54289 | |
| EGLAGDEKEMKIGET | 481 | Q05707 | |
| TRDMICAGEKEGGKD | 626 | P48740 | |
| KMREEGEEEGEGEKL | 221 | P09913 | |
| EERKEGAEKMVREAE | 621 | O60645 | |
| AEAEIEAEEGGVEMK | 441 | Q08357 | |
| EKLDVGVRKEVDGMG | 336 | Q92736 | |
| DGKMVEEVDGRATQK | 1056 | P23468 | |
| GDEAKKMAEGKASRE | 16 | O14607 | |
| AVKGDEKMGGEDDEL | 136 | Q12972 | |
| EEEKMREDGGGKDRA | 26 | Q9NX52 | |
| EDGEESREGGKGKEM | 356 | P32745 | |
| EIGETKKTGNEMEKE | 656 | Q96NG3 | |
| TTGAKGGMEIREIED | 991 | Q8NFP9 | |
| KDRKEDAKGMEDEGQ | 121 | O60902 | |
| EEEAEKMLEIGGDKF | 1026 | Q2Y0W8 | |
| DLAMGTDAEGEKIKD | 371 | P61764 | |
| DEKGKLEAEEVMRDS | 181 | O94993 | |
| EKKAGEDLEVSEGLM | 351 | Q8N3C0 | |
| KGMEGSEIVEEDVNK | 111 | Q96AJ1 | |
| AKEGKSEREGESEME | 71 | Q96EI5 | |
| TMADGGAEEEEDRKA | 136 | Q05516 | |
| EKAADESERGMKVIE | 81 | P67936 | |
| MKAERGVEAAEEKFE | 116 | Q96MW7 | |
| AEGKVESEKADMEDG | 4336 | Q15413 | |
| KAEVMEEIEDGRDEG | 311 | O94804 | |
| DGVEGELEESTKLKM | 186 | Q9H5I5 | |
| AMDTGTKEAGKDGRE | 111 | Q9Y6L7 | |
| AAVEKEGEAGAAMEE | 161 | Q9UJ04 | |
| EGEAGAAMEEKKVVQ | 166 | Q9UJ04 | |
| DIDDIFVGKEGTRMK | 316 | P52849 | |
| FVGKEGTRMKVADVE | 321 | P52849 | |
| LEGKIKSVVMEGGEE | 286 | O43151 | |
| ENEGEEAKTEGLMKD | 1081 | P37275 | |
| AEKAADESERGMKVI | 116 | P09493 | |
| GLREEGEDSMAQEEK | 361 | Q9H6Y2 | |
| AEKAADESERGMKVI | 116 | P07951 | |
| DKIGMEVKVDSDAGI | 286 | Q5SRN2 | |
| EINKGGDRKVEEEMK | 406 | Q6S5H5 | |
| EINKGGDRKVEEEMK | 406 | A6NI47 | |
| EAEKAADESERGMKV | 116 | P06753 | |
| IGTEKAEKNEGRMDA | 1326 | Q14966 | |
| GEREVMEKLVKRDSG | 496 | Q9NUA8 | |
| AMGQEKDGEERDSKE | 931 | Q9H0D2 | |
| GDKSEYLEMEEGVKE | 606 | P22459 | |
| GGQEMMEVVKRDDET | 241 | Q9H6V9 | |
| VDVDEGKLKGETMDL | 51 | Q6ZMR3 | |
| KDGEDEFVKEMREER | 201 | Q5T7N2 |